Allergan Patents Sold to Tribe Are Invalidated by U.S. Judge

摘要

Allergan Plc's bid to use an Indian tribe to protect the eye drug Restasis from the scrutiny of a patent review board fell apart Oct. 16 after a federal judge said the patents don't cover a new invention {Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. el al, E.D. Tex., No. 2:15-cv-01455, 10/16/17).